Polynovo Ltd operates within the Noncommercial research organizations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Polynovo Ltd with three other miscellaneous service companies in Australasia: Pharmaxis Ltd (2019 sales of 12.55 million Australian Dollars [US$8.59 million] of which 48% was New Drug Development), Idt Australia Limited. (12.13 million Australian Dollars [US$8.30 million] ), and Farmaforce Ltd (11.71 million Australian Dollars [US$8.02 million] ).

Sales Analysis. During the year ended June of 2019, sales at Polynovo Ltd were A$13.68 million (US$9.37 million). This is an increase of 128.4% versus 2018, when the company's sales were A$5.99 million. This was the fourth straight year of sales growth at Polynovo Ltd.